ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,613Medicare Part D Prescriptions Filled, Including Refills

Rank: 303 out of 1677

$435K Total Retail Price of All Prescriptions

Rank: 451 out of 1677

618 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 618 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 8,328 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
AMLODIPINE BESYLATE 641 516 1 2
LISINOPRIL 612 478 2 3
SIMVASTATIN 558 463 3 1
HYDROCHLOROTHIAZIDE 440 371 4 9
NEXIUM 412 351 5 19
FUROSEMIDE 327 253 6 8
METFORMIN HCL 326 259 7 7
TRAMADOL HCL 246 158 8 16
CRESTOR 235 189 9 28
LANTUS 222 181 10 44
CARVEDILOL 219 177 11 20
LOSARTAN-HYDROCHLOROTHIAZIDE 207 149 12 42
FLUTICASONE PROPIONATE 194 148 13 29
METOPROLOL SUCCINATE 185 164 14 23
IBUPROFEN 177 140 15 83
METOPROLOL TARTRATE 159 111 16 12
LEVOTHYROXINE SODIUM 158 128 17 5
POTASSIUM CHLORIDE 155 135 18 14
DOXAZOSIN MESYLATE 154 113 19 90
CLONIDINE HCL 153 93 20 36
RANITIDINE HCL 148 129 21 18
LOSARTAN POTASSIUM 129 109 22 25
GLIMEPIRIDE 126 115 23 33
HYDRALAZINE HCL 124 108 24 69
XOPENEX HFA 117 92 25 248
ATENOLOL 113 95 26 21
TRIAMTERENE-HCTZ 113 91 26 61
ISOSORBIDE MONONITRATE ER 105 93 28 73
TOPROL XL 97 82 29 215
COZAAR 93 83 10 30 254
ACETAMINOPHEN-CODEINE 92 84 S3 31 136
LABETALOL HCL 78 74 32 195
TRIAMCINOLONE ACETONIDE 77 66 33 134
SYMBICORT 77 62 33 150
OMEPRAZOLE 74 52 35 6
NAPROXEN 71 46 36 87
CYCLOBENZAPRINE HCL 71 38 R 36 52
GABAPENTIN 70 29 38 11
TRAZODONE HCL 67 52 39 37
FELODIPINE ER 66 54 40 193
SERTRALINE HCL 64 37 41 26
LIDOCAINE 64 56 41 449
NOVOLIN 70-30 62 32 43 155
ALLOPURINOL 60 45 44 31
TRIAMTERENE-HYDROCHLOROTHIAZID 60 31 44 213
AMITRIPTYLINE HCL 59 34 R 46 63
ACTOS 59 56 46 104
PROAIR HFA 59 46 46 50
PAROXETINE HCL 59 26 46 67
GLIPIZIDE ER 57 50 50 78
VENTOLIN HFA 55 41 51 89
INSULIN SYRINGE 54 36 52 72
OXYBUTYNIN CHLORIDE 53 44 53 149
ALENDRONATE SODIUM 52 50 54 43
CLOPIDOGREL 51 42 55 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.